Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-06-Speech-3-364-250"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110406.29.3-364-250"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted against the draft regulation aiming to authorise the health claim that docosahexaenoic acid (DHA) intake contributes to the normal visual development of infants up to 12 months of age.
While a majority of Members voted in favour of this rejection, there were 40 votes too few to reach the qualified majority required to validate the rejection. However, Regulation (EC) No 1924/2006 of the European Parliament and of the Council prescribes that nutrition and health claims must not be misleading and must be based on scientific evidence. Further, even if generally accepted scientific evidence shows that DHA in breast milk contributes to the visual development of infants, there is currently no scientific consensus on a possible causal relationship between the intake of formula supplemented with synthesised DHA and better visual development of infants.
It seems to me that, in the absence of a scientific consensus, there is a need for more research into the possible effects, both beneficial and harmful, of DHA supplementation before the use of DHA in follow-on formulae and foods for infants can be claimed in the EU to be beneficial. Parliament failed, today, to take advantage of the opportunity to prohibit the forthcoming use of this claim pending more convincing scientific evidence. I regret that."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples